These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7669179)

  • 21. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats.
    Shannon HE; Eberle EL; Mitch CH; McKinzie DL; Statnick MA
    Neuropharmacology; 2007 Dec; 53(8):930-41. PubMed ID: 17959202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice.
    De Lander GE; Keil GJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):943-51. PubMed ID: 8114009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
    Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
    J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
    J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
    Albert-Vartanian A; Boyd MR; Hall AL; Morgado SJ; Nguyen E; Nguyen VP; Patel SP; Russo LJ; Shao AJ; Raffa RB
    J Clin Pharm Ther; 2016 Aug; 41(4):371-82. PubMed ID: 27245498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of a chemical series as a drug discovery strategy.
    Lednicer D
    Drug Des Deliv; 1987 Sep; 2(1):69-78. PubMed ID: 3334546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms.
    Chen H; Winiwarter S; Fridén M; Antonsson M; Engkvist O
    J Mol Graph Model; 2011 Aug; 29(8):985-95. PubMed ID: 21571561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropharmacological research on a newly synthesized derivative of 2-aminotetralin].
    Shakur M; Raĭnova L; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1986; 25(4):16-20. PubMed ID: 3816645
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mode of action of non-narcotic analgesics].
    Bannwarth B; Chaslerie A; Schaeverbeke T; Vinçon G; Dehais J; Begaud B
    Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):267-70. PubMed ID: 1496274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of endomorphins and the blood-brain barrier--a review.
    Perlikowska R; Janecka A
    Med Chem; 2014; 10(1):2-17. PubMed ID: 23984851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the effect of DMSO on the penetration of toxogonin into the central nervous system].
    Rump S; Faff J; Edelwejn Z
    Acta Physiol Pol; 1969; 20(5):813-8. PubMed ID: 5385329
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical approaches to drug delivery to the central nervous system.
    Gardner CR
    Psychopharmacol Bull; 1985; 21(3):657-62. PubMed ID: 4034882
    [No Abstract]   [Full Text] [Related]  

  • 36. The synthesis of some 1,1-diphenyl-1-alkoxy-3-alkylamino-2-propanones of biological interest.
    Kourounakis P; Chilliard N
    Pharmazie; 1982 Dec; 37(12):825-7. PubMed ID: 6131445
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and analgesic activity evaluation of some agmatine derivatives.
    He H; Liu M; Zheng Z; Liu Y; Xiao J; Su R; Hu C; Li J; Li S
    Molecules; 2006 Jun; 11(6):393-402. PubMed ID: 17962772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Pharmacological studies on centrally-acting drugs belonging to enaminone mannich bases.
    Káse Y; Masaki K; Miyata T; Takahama K; Saita M
    Jpn J Pharmacol; 1974; 24(0):s:85. PubMed ID: 4545762
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in the central nervous system of rats following intracerebral injection of ouabain].
    Zelman IB
    Neuropatol Pol; 1972; 10(3):423-32. PubMed ID: 5078165
    [No Abstract]   [Full Text] [Related]  

  • 40. [Participation of the central nervous system in the formation of the body reaction to hydrogen sulfide baths].
    Kaplun SIa; Kopteva EG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1974; 0(3):233-7. PubMed ID: 4410332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.